摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

N-(2-(1-benzylpiperidin-4-yl)ethyl)-3-(3,5-di-tert-butyl-4-hydroxyphenyl)propanamide

中文名称
——
中文别名
——
英文名称
N-(2-(1-benzylpiperidin-4-yl)ethyl)-3-(3,5-di-tert-butyl-4-hydroxyphenyl)propanamide
英文别名
N-[2-(1-benzylpiperidin-4-yl)ethyl]-3-(3,5-ditert-butyl-4-hydroxyphenyl)propanamide
N-(2-(1-benzylpiperidin-4-yl)ethyl)-3-(3,5-di-tert-butyl-4-hydroxyphenyl)propanamide化学式
CAS
——
化学式
C31H46N2O2
mdl
——
分子量
478.718
InChiKey
YQDALLBKLTWBJF-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    7.1
  • 重原子数:
    35
  • 可旋转键数:
    10
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.58
  • 拓扑面积:
    52.6
  • 氢给体数:
    2
  • 氢受体数:
    3

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为产物:
    描述:
    3-(3,5-二叔丁基-4-羟基苯基)丙酸4-(2-氨基乙基)-1-苄基哌啶1-羟基苯并三唑盐酸-N-乙基-Nˊ-(3-二甲氨基丙基)碳二亚胺 作用下, 反应 1.0h, 以64%的产率得到N-(2-(1-benzylpiperidin-4-yl)ethyl)-3-(3,5-di-tert-butyl-4-hydroxyphenyl)propanamide
    参考文献:
    名称:
    Donepezil-butylated hydroxytoluene (BHT) hybrids as Anti-Alzheimer's disease agents with cholinergic, antioxidant, and neuroprotective properties
    摘要:
    The multifactorial nature of Alzheimer's disease (AD) calls for the development of multitarget agents addressing key pathogenic processes. A novel family of donepezil-butylated hydroxytoluene (BHT) hybrids were designed, synthesized and evaluated as multifunctional ligands against AD. The optimal compound 7d displayed a balanced multifunctional profile covering an intriguing acetylcholinesterase (AChE) inhibition (IC50, 0.075 mu M for eeAChE and 0.75 mu M for hAChE) and Monoamine oxidase B (MAO-B) inhibition (IC50, 7.4 mu M for hMAO-B), excellent antioxidant activity (71.7 mu M of IC50 by DPPH method, 0.82 and 1.62 trolox equivalent by ABTS method and ORAC method respectively), and inhibitory effects on self-induced, hAChE-induced A beta aggregation. Moreover, 7d possessed neuroprotective potency against H2O2-induced oxidative damage on PC12 cells and Lipopolysaccharides (LPS)-stimulated inflammation on BV2 cells. Compound 7d was capable of penetrating BBB and presented good liver microsomal metabolic stability. Importantly, compound 7d could dose-dependently reverse scopolamine-induced memory deficit in mice without acute toxicity. Taken together, those outstanding results highlight the donepezil-BHT hybrid 7d as a promising prototype in the research of innovative compound for AD. (C) 2018 Elsevier Masson SAS. All rights reserved.
    DOI:
    10.1016/j.ejmech.2018.08.005
点击查看最新优质反应信息

文献信息

  • Donepezil-butylated hydroxytoluene (BHT) hybrids as Anti-Alzheimer's disease agents with cholinergic, antioxidant, and neuroprotective properties
    作者:Pei Cai、Si-Qiang Fang、Hua-Li Yang、Xue-Lian Yang、Qiao-Hong Liu、Ling-Yi Kong、Xiao-Bing Wang
    DOI:10.1016/j.ejmech.2018.08.005
    日期:2018.9
    The multifactorial nature of Alzheimer's disease (AD) calls for the development of multitarget agents addressing key pathogenic processes. A novel family of donepezil-butylated hydroxytoluene (BHT) hybrids were designed, synthesized and evaluated as multifunctional ligands against AD. The optimal compound 7d displayed a balanced multifunctional profile covering an intriguing acetylcholinesterase (AChE) inhibition (IC50, 0.075 mu M for eeAChE and 0.75 mu M for hAChE) and Monoamine oxidase B (MAO-B) inhibition (IC50, 7.4 mu M for hMAO-B), excellent antioxidant activity (71.7 mu M of IC50 by DPPH method, 0.82 and 1.62 trolox equivalent by ABTS method and ORAC method respectively), and inhibitory effects on self-induced, hAChE-induced A beta aggregation. Moreover, 7d possessed neuroprotective potency against H2O2-induced oxidative damage on PC12 cells and Lipopolysaccharides (LPS)-stimulated inflammation on BV2 cells. Compound 7d was capable of penetrating BBB and presented good liver microsomal metabolic stability. Importantly, compound 7d could dose-dependently reverse scopolamine-induced memory deficit in mice without acute toxicity. Taken together, those outstanding results highlight the donepezil-BHT hybrid 7d as a promising prototype in the research of innovative compound for AD. (C) 2018 Elsevier Masson SAS. All rights reserved.
查看更多